rs3741040
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PP3PP5_ModerateBP4BS2_Supporting
The NM_001025389.2(AMPD3):c.1717C>T(p.Arg573Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000245 in 1,614,242 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R573H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001025389.2 missense
Scores
Clinical Significance
Conservation
Publications
- adenosine monophosphate deaminase deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152238Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.000322 AC: 81AN: 251452 AF XY: 0.000287 show subpopulations
GnomAD4 exome AF: 0.000254 AC: 372AN: 1461886Hom.: 3 Cov.: 37 AF XY: 0.000246 AC XY: 179AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.000151 AC: 23AN: 152356Hom.: 0 Cov.: 34 AF XY: 0.000174 AC XY: 13AN XY: 74508 show subpopulations
ClinVar
Submissions by phenotype
Erythrocyte AMP deaminase deficiency Pathogenic:1Other:1
- -
The AMPD3 c.1717C>T (p.Arg573Cys) missense variant has been reported in two studies in which it is found in a total of 51 Japanese individuals with erythrocyte AMP deaminase deficiency, including in four homozygotes with a complete deficiency and in 47 heterozygotes with a partial deficiency (Yamada et al. 1994a; Yamada et al. 1994b). The variant was absent from over 2500 controls but is reported at a frequency of 0.00416 in the East Asian population of the Exome Aggregation Consortium. Functional studies by Yamada et al. (1994a) showed that the p.Arg573Cys variant results in a catalytically inactive but stable peptide. Based on the evidence the p.Arg573Cys variant is classified as pathogenic for erythrocyte AMP deaminase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
AMPD3-related disorder Pathogenic:1
The AMPD3 c.1717C>T variant is predicted to result in the amino acid substitution p.Arg573Cys. This variant has been reported to be causative for autosomal recessive adenosine monophosphate deaminase deficiency in multiple individuals, and functional studies support its pathogenicity (Yamada et al. 1994. PubMed ID: 8004104; Yamada et al. 1994. PubMed ID: 7881427; Hou et al. 2020. PubMed ID: 31980526). This variant is reported in 0.42% of alleles in individuals of East Asian descent in gnomAD. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at